Clinical Trial Update: A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study evaluating intravenous sodium nitroprusside in adults with schizophrenia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Sodium nitroprusside (sodium nitroprusside)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2018-10-02